Related Experiment Videos
Augmentation in restless legs syndrome is associated with low ferritin
Claudia Trenkwalder1, Birgit Högl, Heike Benes
1Paracelsus-Elena Hospital, Kassel, Germany. ctrenkwalder@gmx.de
Background And Purpose:
Augmentation is a major problem with dopaminergic therapy for restless legs syndrome (RLS), and predictors of augmentation have not yet been identified. We aimed to analyze the relationship between baseline ferritin level and occurrence of augmentation in a retrospective analysis of a prospective double-blind trial of cabergoline versus levodopa on augmentation in RLS.
Patients And Methods:
Patients who experienced augmentation were compared to patients who did not experience augmentation.
Results:
Augmentation symptoms causing premature discontinuation from the study or which were tolerated (n=36, ferritin: 85+59 ng/ml) were associated with lower levels of serum ferritin compared to patients without augmentation (n=302, ferritin: 118+108 ng/ml, p=0.0062).
Conclusions:
Ferritin as a marker of iron storage may play an important role in the pathophysiology of RLS and may prove to be a biomarker for the development of augmentation under dopaminergic therapy.
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Alterations in Muscle Tone lll
REM Sleep Behavior Disorder
RBD is significantly associated with...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Alterations in Muscle Tone ll
Acid Mine Drainage